In exchange, 3SBio will receive $1.25bn upfront from Pfizer and will be eligible for certain development, regulatory and ...

VML France has announced the appointment of Philippe Huot-Louradour as director of VML Health France. Hout, who has also been ...

Merck & Co – known as MSD outside of the US and Canada – has announced that its Welireg (belzutifan) has been approved by the ...

In an era where clinician time is stretched thin, AI and digital innovation are transforming continuing medical education ...

Understanding why people join clinical trials is essential to improving recruitment and designing better research. Explores ...

Johnson & Johnson (J&J) has received approval from the Medicines and Healthcare products Regulatory Agency (MHRA) for its ...

The US Food and Drug Administration (FDA) has approved Fujirebio Diagnostics’ Alzheimer’s disease (AD) blood test to help ...

Merck & Co – known as MSD outside the US and Canada – has received approval from the Medicines and Healthcare products ...

The US regulator’s decision was supported by results from the phase 3 HELIOS-B trial, in which Alnylam’s drug reduced the risk of all-cause mortality (ACM) and recurrent cardiovascular events by 28% ...

Sanofi has unveiled plans to invest “at least” $20bn into the US by 2030, with the commitment including a significant ...

AbbVie and ADARx Pharmaceuticals have announced a multi-billion dollar partnership to develop small interfering RNA (siRNA) ...

AbbVie’s Emrelis (telisotuzumab vedotin-tllv) has been granted accelerated approval by the US Food and Drug Administration ...